| 000 | 01516 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515090156.0 | ||
| 264 | 0 | _c20080107 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdm455 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Veldt, A A M | |
| 245 | 0 | 0 |
_aReversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cOct 2007 |
||
| 300 |
_a1747-50 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCognition Disorders _xchemically induced |
| 650 | 0 | 4 |
_aDementia, Vascular _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xadverse effects |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPyrroles _xadverse effects |
| 650 | 0 | 4 | _aSunitinib |
| 700 | 1 | _avan den Eertwegh, A J M | |
| 700 | 1 | _aHoekman, K | |
| 700 | 1 | _aBarkhof, F | |
| 700 | 1 | _aBoven, E | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 18 _gno. 10 _gp. 1747-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdm455 _zAvailable from publisher's website |
| 999 |
_c17413373 _d17413373 |
||